TrialThe oncologist2017

A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.

Min-Hee Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.